Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Bernadette Connaughton currently holds 6,040 shares of Editas Medicine, Inc. (EDIT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Bernadette Connaughton has been a net seller of EDIT stock. They have purchased $0 and sold $641.5K worth of shares.
Bernadette Connaughton's most recent insider trade was on May 5, 2026, when they sold 6,040 shares at $0.00 per share.
Bernadette Connaughton serves as Executive at Editas Medicine, Inc. (EDIT). They have executed 26 insider transactions totaling $641.5K over their tenure at the company.
Bernadette Connaughton holds the position of Executive at Editas Medicine, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 8 years and currently hold a stake valued at $0.
Bernadette Connaughton has shown a selling trading pattern, with $0 in total purchases and $641.5K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Bernadette Connaughton was on Sep 28, 2023, when they sold $426.3K worth of SYNH shares. This transaction involved 9,915 shares at $43.00 per share.
Bernadette Connaughton currently owns 6,040 shares of Editas Medicine, Inc. (EDIT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Bernadette Connaughton's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Bernadette Connaughton has 26 Form 4 filings on record as an insider at Editas Medicine, Inc..
Set alerts for Bernadette Connaughton and 40,000+ other insiders.